Lyell Immunopharma, Inc.

NASDAQ:LYEL

1.27 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -45.809-60.667-52.93-50.853-63.89-66.959-8.397-70.254-36.323-68.144-83.706-48.875-62.595-55.043-38.857-35.719-100.656-29.24
Depreciation & Amortization 4.9015.0245.0575.1045.0625.0275.0414.6214.1714.1874.5654.0913.011.9581.4521.1040.9620.776
Deferred Income Tax 00-18.152-1.6451.278093.89600037.3771.090.9960.043-4.3840.213-0.061-1.38
Stock Based Compensation 8.2849.1558.46310.51614.22313.88218.36319.12322.4122.02821.17813.04215.24912.73212.9719.7487.2683.274
Change In Working Capital -0.954-3.2371.7222.4263.584-4.311-43.3931.749-37.982-2.3893.6185.739-0.565-4.7772.1110.371-2.272-0.546
Accounts Receivables 000000000000000000
Change In Inventory 000000000000000000
Change In Accounts Payables -0.517-0.1130.425-1.410.382.069-0.5260.023-1.7672.9370.099-0.9880.3460.6340.338-0.293-1.2440.921
Other Working Capital -0.437-3.1241.2973.8363.204-6.38-42.8671.726-35.742-5.3263.5196.727-0.911-5.4111.7730.664-1.028-1.467
Other Non Cash Items 14.08727.02515.205-3.2340.5826.149-105.7777.6583.146-3.534-16.205-0.6199.95811.49-0.0252.6555.8373.524
Operating Cash Flow -38.094-42.016-40.635-37.686-39.161-46.212-40.267-37.103-44.333-47.852-33.173-25.532-33.947-33.597-26.732-21.628-88.922-23.592
Investing Activities:
Investments In Property Plant And Equipment -0.331-0.03-0.025-0.195-0.933-1.533-4.582-2.791-7.17-9.733-10.268-11.599-24.447-19.19-24.881-12.641-7.078-6.881
Acquisitions Net 00100.66578.2833.255-33.6870160.792096.196-0.0400.0400000
Purchases Of Investments -116.464-108.011-256.785-78.28-33.255-108.56-220.461-160.792-89.659-96.196-673.465-275.311-215.939-48.291-7.001000
Sales Maturities Of Investments 161.802130.035156.12178.147187.1142.247110.899106.498121.84879.80770.33142.036200.872204.158205.691173.096177.701129.834
Other Investing Activites 45.33822.024-100.665-78.28-33.25533.687160.792-160.79232.189-96.196539.501-275.311-215.899-48.291-141.422-250.4-270.502-239.032
Investing Cash Flow 45.00721.994-100.6999.672152.91232.15446.648-57.08525.019-26.122-73.902-144.874-39.474136.67732.387-89.945-99.879-116.079
Financing Activities:
Debt Repayment 000000000000000000
Common Stock Issued 0.8620.1030.8820.0721.24609.5775.1271.572.55510.502-1.06393.4920.8840000
Common Stock Repurchased 0.81-0.076-0.123-0.215-0.05-0.069-0.094-0.367000-0.53100000-16.05
Dividends Paid 000000000000000000
Other Financing Activities 0.862-0.0760.8820.0721.246-0.069-8.62-0.3672.4572.555-3.1030.529393.4920.8840.3380.035-0.002492.469
Financing Cash Flow 0.8620.0270.759-0.1431.196-0.0690.8634.762.4572.5557.399-0.531393.4920.8840.3380.035-0.002476.419
Other Information:
Effect Of Forex Changes On Cash 00-0.001-102.39500000000000000
Net Change In Cash 7.774-19.997-140.56761.843114.947-14.1277.244-89.428-16.857-71.419-99.676-170.937320.071103.9645.993-111.538-188.803336.748
Cash At End Of Period 133.424125.65145.647286.497224.654109.707123.834116.59206.018222.875294.294393.97564.907244.836140.872134.879246.417435.22